State warns Ramdev’s firm against advertising ‘Coronil’

Published - July 04, 2020 12:16 am IST - Mumbai

The Maharashtra government on Friday warned Baba Ramdev’s company, Patanjali, to not advertise its product ‘Coronil’ as a cure for COVID-19 and to be ready to face action if it did.

State Food and Drug Administration Minister Rajendra Shingane said that ‘Coronil’ was nothing but a tablet made up of aswagandha, tulsi and giloy (gulvel). “It has been observed that ‘Coronil’ is being advertised as a cure for COVID-19. It is not true.”

The minister said the Centre’s Aayush Ministry had recommended medicines with such ingredients only to increase immunity. “The name ‘Coronil’ and the publicity campaign to promote it had created doubts in the minds of the people. We want to inform the public that this tablet is not a cure for the novel coronavirus.”

Mr. Shingane said his department had been given clear directions to keep a watch on publicity campaigns and advertisements for ‘Coronil.’ “We have also requested the Home Department to keep a watch. Failing to adhere to the guidelines will result in action under the relevant sections of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954,” he said.

The State government, meanwhile, has asked zilla parishads to distribute Homeopathic medicines such as Arsenicum Album 30 and a few Ayurvedic medicines suggested by the Ayush Ministry to five crore citizens free of cost.

Rural Development Minister Hasan Mushreef has directed all zilla parishads to ensure that the entire process of finalising and distributing the medicines is completed within three weeks.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.